Displaying 421 - 440 of 853
| Active Ingredient | BENZTROPINE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (PARKINSONS) |
| Indications | Symptomatic treatment of parkinsonism. Alleviation of drug induced extrapy ramidal disorders, but is of no value against tardive dyskinesias. |
| Caution | Urinary retention, blurred vision, nervousness, confusion, drowsiness. |
| Dose Range |
Adult and Children over 12 years: 0.5-1mg daily at bedtime gradually increased to a maximum of 6mg daily . Maintenance dose of 1-4mg daily as a single dose or in divided doses. i.v. or i.m: 1-2mg, repeated until symptoms disappear. Pediatri |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PROCYCLIDINE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (PARKINSONS) |
| Indications | Parkinsonism. |
| Caution | Blurred vision, mydriasis, disorientation, lightheadedness, nausea, vomiting, xerostomia. Safety and effective not established for Pediatric patients. |
| Dose Range | Adult: 2.5mg 3 times a day . M aintenance dose 10-30mg 3-4 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BENSERAZIDE | LEVODOPA |
| Therapeutic Class | DOPAMINE PRECURSORS |
| Indications | Parkinsonism, especially when akinesia is the most prominent feature. Alternative to Sinemet (L-dop a and Carbidop a), as one may be better tolerated than the other. |
| Caution | Vomiting, anorexia, nausea, severe anxiety, insomnia, dizziness, postural hypotension, urinary retention. Red discoloration of the urine and other body fluids. |
| Dose Range | 50-100mg twice daily to a usual maintenance dose of 400-800mg daily in divided doses after meals. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CARBIDOPA | LEVODOPA |
| Therapeutic Class | DOPAMINE PRECURSORS |
| Indications |
Parkinsonism, especially when akinesia is most prominent feature. Alternative to Madopar (Levodopa/ Benserazide), as one may be better tolerated than the other. |
| Caution | Abdominal pain,anorexia, nausea,severe anxiety, dizziness, postural hypotension, urinary retention. |
| Dose Range | Initially one tablet (either strength) 3 times daily , increase by one tablet daily or every other day to a maximum of 8 tablets daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BROMOCRIPTINE |
| Therapeutic Class | DOPAMINE RECEPTOR AGONIST |
| Indications |
Hyperprolactinemia (Amenorrhoea, female infertility ); parkinsonism; suppression of lactation. |
| Caution | Nausea, hypotension, headache, peripheral vasocontriction. The use of Bromocrip tine for the sup p ression of post -partum lactation has been withdrawn by the FDA due to severe side effects report More ... |
| Dose Range |
Amenorrhea second to hyperprolactinemia: 2.5mg-5mg 2 times daily .Parkinsonism: 1.25-2.5mg twice daily .Take with food or milk. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CABERGOLINE |
| Therapeutic Class | DOPAMINE RECEPTOR AGONIST |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ATOMOXETINE |
| Therapeutic Class | CENTRAL NERVOUS SYSTEM AGENTS, MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUMAZENIL |
| Therapeutic Class | CENTRAL NERVOUS SYSTEM AGENTS, MISCELLANEOUS |
| Indications | Reversal of benzodiazep ine-induced sedation. |
| Caution | Nausea, vomiting dizziness, increased sweating, pain at injection site, headache, and abnormal or blurred vision. |
| Dose Range |
200 microgramsadministered over 15 seconds, then 100 micrograms every 1 minute if required to a maximum total dose of 1 mg or occasionally 2 mg. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIAGNOSTIC BLOOD GLUCOSE |
| Therapeutic Class | DIABETES MELLITUS |
| Indications |
Blood glucose monitoring. The BDS will reimburse for one bottle of 50’s testing strip s every 3 months to patients on oral diabetic medication or those diabetic patients controlled on diet an More ... |
| Caution |
Patients should be properly trained in the use of blood glucose monitoring sy stems. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BARIUM SULPHATE |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | Examination of the gastrointestinal tract . |
| Caution | Constipation. |
| Dose Range | Dependent on the type of examination being undertaken. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BETAINE | SOD BIC | DIMETHICONE |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | Double contrast radiograp hy of the G.I. tract. |
| Caution | Stomach cramps, belching. |
| Dose Range | As for Barium Sulphate. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CITRIC ACID | SIMETHICONE | SODIUM BICARBONATE |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | GADOBUTROL |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | Imaging of the CNS, kidneys, and liver, and in magnetic resonance angiography . |
| Caution | May prolong cardiac repolarisation and should not be used in patients with uncorrected hypokalaemia |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | GADOPENTETATE |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications |
Magnetic resonance imaging of cranial and spinal structures, and of the whole body . |
| Caution | Headache, nausea, vomiting, dizziness, and transient sensations of heat or cold or taste disturbances. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IOHEXOL |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IOPROMIDE |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | Iodinated radiographic contrast mediumused in angiography, arthrography, hy sterosalp ingography, urography, and assessment of dialysis shuntpatency . |
| Caution | Flushing or a sensation of heat . |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IOVERSOL |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | Ioversol is an iodinated radiographic contrast medium that is given intra-arterially or intravenously for angiography and urography. For other procedures, it can be injected into body cavity or inject More ... |
| Caution | Most reactions occur within 5 to 10 minutes and are mild and transient; however, severe, life-threatening reactions may also occur, and delayed reactions have been reported. Common side effect is flus More ... |
| Dose Range | Ioversol injection 64% (marketed as Optiray 300) - bolus injection: 25 to 75 mL, infusion: 50 to 150 mL Ioversol injection 68% (marketed as Optiray 320) - bolus injection: 25 to 75 mL, infusion: 50 to 150 mL Ioversol injection 74% (marketed as Optiray 350 |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MEGLUMINE IOTHALAMATE |
| Therapeutic Class | ROENTGENOGRAPHY |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIAGNOSTIC PROTEINURIA TEST |
| Therapeutic Class | URINE CONTENTS |
| Indications | Use to detect protein, blood,glucose & ketonein urine samples. |
| Caution | |
| Dose Range | a thin plastic stick with chemicals on the tip – to test part of the sample right away. If too much of any substance is in the urine, the chemical tip changes color. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIAGNOSTIC URINE |
| Therapeutic Class | URINE CONTENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |